JGC
J. Goldman & Co’s Arcutis Biotherapeutics ARQT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.1M | Buy |
860,260
+679,739
| +377% | +$9.53M | 0.29% | 91 |
|
|
2025
Q1 | $2.82M | Sell |
180,521
-432,123
| -71% | -$6.76M | 0.07% | 175 |
|
|
2024
Q4 | $8.53M | Sell |
612,644
-879,573
| -59% | -$12.3M | 0.22% | 108 |
|
|
2024
Q3 | $13.9M | Buy |
1,492,217
+180,668
| +14% | +$1.68M | 0.39% | 59 |
|
|
2024
Q2 | $12.2M | Sell |
1,311,549
-123,769
| -9% | -$1.15M | 0.35% | 79 |
|
|
2024
Q1 | $14.2M | Buy |
1,435,318
+1,267,585
| +756% | +$12.6M | 0.46% | 54 |
|
|
2023
Q4 | $542K | Buy |
+167,733
| New | +$542K | 0.02% | 168 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 237 |
|